Literature DB >> 10442299

Difficulties in measuring the effect of testosterone replacement therapy on muscle function in older men.

J E Clague1, F C Wu, M A Horan.   

Abstract

Muscle wasting in older men may be related to androgen deficiency. We have assessed the effect of testosterone replacement therapy on muscle function in the upper and lower limbs of older (age > 60 years) men with blood testosterone levels < 14 nmol/L. Subjects (n = 7 per group) received testosterone enanthate 200 mg i.m. or placebo every 2 weeks in a double blind study over a 12-week period and underwent muscle testing every 4 weeks. A significant increase in blood levels of testosterone and a reduction in levels of sex hormone binding globulin occurred in the treatment group. Total body mass, haemoglobin and packed cell volume also increased significantly (p < 0.05). No improvements in handgrip strength, isometric strength of knee flexors and extensors or leg extensor power were seen in either group. Wide variability in all measures of muscle function were observed in these elderly men suggesting that very large study groups would be required to determine potential treatment benefits on muscle function.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10442299     DOI: 10.1046/j.1365-2605.1999.00177.x

Source DB:  PubMed          Journal:  Int J Androl        ISSN: 0105-6263


  18 in total

1.  Beneficial effects of topical testosterone replacement in patients with end-stage liver disease.

Authors:  Guy W Neff; Christopher B O'Brien; Marzia Montalbano; Douglas Meyer; Antoinette DeManno; Halim Muslu; Kamran Safdar; Stephanie Kahn; Seigo Nishida; Eugene R Schiff
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

Review 2.  Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?

Authors:  Manthos G Giannoulis; Finbarr C Martin; K Sreekumaran Nair; A Margot Umpleby; Peter Sonksen
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

Review 3.  Validated treatments and therapeutics prospectives regarding pharmacological products for sarcopenia.

Authors:  G Onder; C Della Vedova; F Landi
Journal:  J Nutr Health Aging       Date:  2009-10       Impact factor: 4.075

4.  Value of measuring muscle performance to assess changes in lean mass with testosterone and growth hormone supplementation.

Authors:  E Todd Schroeder; Jiaxiu He; Kevin E Yarasheski; Ellen F Binder; Carmen Castaneda-Sceppa; Shalender Bhasin; Christina M Dieli-Conwright; Miwa Kawakubo; Ronenn Roubenoff; Stanley P Azen; Fred R Sattler
Journal:  Eur J Appl Physiol       Date:  2011-07-12       Impact factor: 3.078

Review 5.  Relationship between testosterone deficiency and cardiovascular risk and mortality in adult men.

Authors:  C Cattabiani; S Basaria; G P Ceda; M Luci; A Vignali; F Lauretani; G Valenti; R Volpi; M Maggio
Journal:  J Endocrinol Invest       Date:  2011-11-08       Impact factor: 4.256

6.  Androgen treatment and muscle strength in elderly men: A meta-analysis.

Authors:  Kenneth J Ottenbacher; Margaret E Ottenbacher; Allison J Ottenbacher; Ana Alfaro Acha; Glenn V Ostir
Journal:  J Am Geriatr Soc       Date:  2006-11       Impact factor: 5.562

7.  Treatment of Men for "Low Testosterone": A Systematic Review.

Authors:  Samantha Huo; Anthony R Scialli; Sean McGarvey; Elizabeth Hill; Buğra Tügertimur; Alycia Hogenmiller; Alessandra I Hirsch; Adriane Fugh-Berman
Journal:  PLoS One       Date:  2016-09-21       Impact factor: 3.240

8.  Changes in muscle mass, muscle strength, and power but not physical function are related to testosterone dose in healthy older men.

Authors:  Thomas W Storer; Linda Woodhouse; Lynne Magliano; Atam B Singh; Connie Dzekov; Jeanne Dzekov; Shalender Bhasin
Journal:  J Am Geriatr Soc       Date:  2008-09-15       Impact factor: 5.562

9.  Predictors of serum testosterone and DHEAS in African-American men.

Authors:  Matthew T Haren; William A Banks; H M Perry Iii; Ping Patrick; Theodore K Malmstrom; Douglas K Miller; John E Morley
Journal:  Int J Androl       Date:  2008-02

10.  Hypogonadism in the aging male diagnosis, potential benefits, and risks of testosterone replacement therapy.

Authors:  Prasanth N Surampudi; Christina Wang; Ronald Swerdloff
Journal:  Int J Endocrinol       Date:  2012-03-14       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.